AlphaCrest Capital Management’s Healthcare Services Group HCSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-22,654
Closed -$274K 505
2022
Q3
$274K Sell
22,654
-1,890
-8% -$27.9K 0.02% 1167
2022
Q2
$427K Buy
24,544
+7,478
+44% +$129K 0.02% 1002
2022
Q1
$317K Sell
17,066
-28,114
-62% -$485K 0.02% 1093
2021
Q4
$804K Buy
45,180
+24,655
+120% +$479K 0.03% 901
2021
Q3
$513K Buy
20,525
+8,940
+77% +$242K 0.03% 897
2021
Q2
$366K Sell
11,585
-7,287
-39% -$222K 0.02% 1057
2021
Q1
$529K Buy
+18,872
New +$570K 0.03% 772
2020
Q4
Sell
-13,223
Closed -$285K 1179
2020
Q3
$285K Buy
13,223
+4,958
+60% +$116K 0.03% 883
2020
Q2
$202K Buy
+8,265
New +$196K 0.03% 840
2020
Q1
Sell
-30,219
Closed -$735K 1124
2019
Q4
$735K Buy
+30,219
New +$749K 0.06% 528
2019
Q3
Sell
-8,424
Closed -$255K 1280
2019
Q2
$255K Sell
8,424
-9,963
-54% -$329K 0.02% 909
2019
Q1
$607K Buy
+18,387
New +$704K 0.09% 385

Other funds holding HCSG

AlphaCrest Capital Management's HCSG Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Healthcare Services Group (HCSG) in Q4 2022, closing a stake of 22,654 shares — an estimated $274K sold.

AlphaCrest Capital Management first reported a position in HCSG in Q1 2019 and held it in 12 quarters. The position peaked at $804K in Q4 2021. 201 funds tracked by Wall St. Rank hold HCSG as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Healthcare Services Group position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 22,654 Healthcare Services Group shares in Q4 2022, an estimated $274K.
  • AlphaCrest Capital Management first reported a position in Healthcare Services Group in Q1 2019 and held it in 12 quarters.
  • AlphaCrest Capital Management's Healthcare Services Group position peaked at $804K in Q4 2021.
  • 201 funds tracked by Wall St. Rank held Healthcare Services Group as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.